APOLLOHOSP - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.3
| Stock Code | APOLLOHOSP | Market Cap | 1,22,435 Cr. | Current Price | 8,516 ₹ | High / Low | 8,624 ₹ |
| Stock P/E | 81.6 | Book Value | 693 ₹ | Dividend Yield | 0.22 % | ROCE | 17.6 % |
| ROE | 16.1 % | Face Value | 5.00 ₹ | DMA 50 | 8,089 ₹ | DMA 200 | 7,618 ₹ |
| Chg in FII Hold | -0.92 % | Chg in DII Hold | 1.26 % | PAT Qtr | 382 Cr. | PAT Prev Qtr | 392 Cr. |
| RSI | 63.5 | MACD | 125 | Volume | 3,44,794 | Avg Vol 1Wk | 2,96,226 |
| Low price | 6,680 ₹ | High price | 8,624 ₹ | PEG Ratio | 6.88 | Debt to equity | 0.32 |
| 52w Index | 94.4 % | Qtr Profit Var | 14.7 % | EPS | 104 ₹ | Industry PE | 46.3 |
📊 APOLLOHOSP shows strong fundamentals but is currently overvalued. With ROE (16.1%) and ROCE (17.6%), the company demonstrates solid capital efficiency. Debt-to-equity is moderate (0.32), manageable but worth monitoring. The P/E ratio (81.6) is nearly double the industry average (46.3), suggesting stretched valuations. The PEG ratio (6.88) further highlights overvaluation relative to growth. Dividend yield is minimal (0.22%), offering limited passive income. Quarterly PAT declined slightly (392 Cr. to 382 Cr.), showing earnings pressure. EPS (104 ₹) is decent, but RSI (63.5) indicates the stock is nearing overbought territory. Institutional activity is mixed, with FII holdings down (-0.92%) but DII up (+1.26%).
💡 Entry Price Zone: A favorable entry would be between 7,600 ₹ – 8,000 ₹, closer to DMA 200 (7,618 ₹) and DMA 50 (8,089 ₹), where valuations align better with long-term growth potential.
📈 Exit Strategy / Holding Period: If already holding, consider a 3–5 year horizon given strong fundamentals. Partial profit booking may be considered near 8,500–8,600 ₹ if valuations remain stretched. Exit only if earnings growth slows further or if P/E expands without EPS support.
🌟 Positive
- Strong [ROE](ca://s?q=Explain_ROE) of 16.1% and [ROCE](ca://s?q=Explain_ROCE) of 17.6% show solid capital efficiency.
- Moderate [debt-to-equity](ca://s?q=Debt_to_equity_explained) ratio of 0.32 is manageable.
- EPS of 104 ₹ supports earnings visibility.
- DII holdings increased (+1.26%), showing domestic institutional confidence.
⚠️ Limitation
- High [P/E ratio](ca://s?q=Explain_P/E_ratio) of 81.6 compared to industry average of 46.3.
- [PEG ratio](ca://s?q=PEG_ratio_explained) of 6.88 reflects stretched valuations relative to growth.
- Dividend yield of 0.22% offers minimal passive income.
- Quarterly PAT declined slightly (392 Cr. to 382 Cr.).
- FII holdings decreased (-0.92%), reflecting reduced foreign investor interest.
📰 Company Negative News
- Valuation concerns due to high P/E and PEG ratios.
- Quarterly profit decline raises earnings sustainability concerns.
- Reduced foreign institutional confidence.
📢 Company Positive News
- Strong EPS of 104 ₹ highlights earnings power.
- DII holdings increased significantly (+1.26%).
- Solid ROE and ROCE compared to peers.
🏭 Industry
- Industry P/E at 46.3, much lower than company’s 81.6, highlighting sector-wide better valuations.
- Healthcare sector growth driven by rising demand for hospital services, medical infrastructure, and wellness trends.
✅ Conclusion
APOLLOHOSP is fundamentally strong with solid ROE and ROCE, making it a decent candidate for long-term investment. However, valuations are stretched with high P/E and PEG ratios. Entry is ideal near 7,600–8,000 ₹. Long-term investors may hold for 3–5 years, while existing holders can consider partial profit booking near 8,500–8,600 ₹ if momentum sustains. Monitoring quarterly earnings and institutional activity will be crucial for sustained returns.